Position in HIMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,445,136
+$1,003,168 QoQ
Shares Held
70,526
+1.5% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#139
of 504 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pathstone Holdings, LLC holds $42,015,720 across 17 Drug Manufacturers - Specialty & Generic names. HIMS ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
273,446 | $6,729,505 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
177,906 | $6,027,454 | |
| 3 | ZTS |
Zoetis Inc.
|
74,081 | $5,323,460 | |
| 4 | ALKS |
Alkermes plc.
|
82,327 | $4,313,934 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
239,306 | $3,836,074 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
5,129 | $2,779,045 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
This page
|
70,526 | $2,445,136 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
13,005 | $2,191,862 |
All Filings in HIMS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,445,136 | 70,526 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,441,968 | 69,459 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,223,350 | 68,474 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,146,772 | 90,740 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,891,449 | 58,003 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,523,361 | 51,552 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,416,052 | 58,563 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,259,135 | 68,357 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $1,385,174 | 68,607 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,392,593 | 90,019 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $581,035 | 65,285 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||